Citations

Showing 10 of 108119 citations.

Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability
Dubey, Divyanshu , Pittock, Sean J. , McKeon, Andrew , Pittock, S J , McKeon, Andrew , Dubey, Divyanshu

Mayo Clinic

Epilepsia | February 6, 2019 | Volume: 60 | Issue: 2 | Pages: 367-369

10.1111/epi.14649 | PMID 30727035 Get It

We’ve Come This Far by Faith: The Role of the Black Church in Public Health
Williams, David R. , Brewer, LaPrincess C.

Mayo Clinic

American Journal of Public Health | February 6, 2019 | Volume: 109 | Issue: 3 | Pages: 385-386

10.2105/ajph.2018.304939 | PMID 30726121 Get It

Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only
Kahalley, Lisa S. , Ris, M. Douglas , Mahajan, Anita , Okcu, M. Fatih , Chintagumpala, Murali , Whitehead, William E. , Stancel, Heather, Orobio, Jéssica , Xue, Judy, Warren, Emily , Grosshans, David R. , Kahalley, Lisa S , Paulino, Arnold C. , Minard, Charles G.

Mayo Clinic

Neuro-Oncology | February 6, 2019 | Volume: 21 | Issue: 6 | Pages: 809-818

10.1093/neuonc/noz041 | PMID 30753584 Get It

Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension
Mehanna, Mai , Wang, Zhiying , McDonough, Caitrin W. , Beitelshees, Amber L. , Gums, John G. , Chapman, Arlene B. , Schwartz, Gary L. , Bailey, Kent R. , Johnson, Julie A. , Beitelshees, Amber L. , Turner, Stephen T. , Gong, Yan , Cooper‐DeHoff, Rhonda M.

Mayo Clinic

American Journal of Hypertension | February 6, 2019 | Volume: 32 | Issue: 7 | Pages: 668-675

10.1093/ajh/hpz022 | PMID 30753254 Get It

Abstract BACKGROUND Interindividual variability in blood pressure (BP) response to antihypertensives has been reported. Although plasma renin activity (PRA) is a potential biomarker for personalizing antihypertensive therapy in European American (EA) and African American (AA) hypertensives, clinical utility of PRA-guided prescribing is incompletely understood. METHODS Using systematic-phased approach, PRA’s clinical utility was assessed. After categorizing by baseline PRA, clinic systolic BP (SBP) responses to metoprolol and chlorthalidone were compared in 134 EAs and 102 AAs enrolled in the Pharmacogenomics Evaluation of Antihypertensive Responses-2 (PEAR-2) trial. Receiver operating characteristic (ROC) analysis was conducted in EAs. Data from PEAR-2 AAs were used to estimate an optimal PRA cut point using multivariable linear regression models. The derived cut point in AAs was tested in a meta-analysis of 2 independent AA cohorts, and its sensitivity and specificity were assessed. RESULTS EAs with PRA < 0.65 ng/ml/hour had a greater decrease in SBP to chlorthalidone than metoprolol (by –15.9 mm Hg, adjusted P < 0.0001), whereas those with PRA ≥ 0.65 ng/ml/hour had a greater decrease in SBP to metoprolol than chlorthalidone (by 3.3 mm Hg, adjusted P = 0.04). Area under ROC curve (0.69, P = 0.0001) showed that PRA can predict SBP response among EAs. However, we observed no association between PRA and SBP response in PEAR-2 AAs. Among independent AA cohorts, those with PRA ≥ 1.3 ng/ml/hour (PEAR-2-derived cut point) responded better to atenolol/candesartan than hydrochlorothiazide (meta-analysis P = 0.01). However, sensitivity of the derived cut point was 10%. CONCLUSIONS PRA at the previously established 0.60–0.65 ng/ml/hour cut point is an effective predictive biomarker of BP response in EAs. However, we were unable to identify PRA cut point that could be used to guide antihypertensive selection in AAs. TRIAL REGISTRATION NCT01203852, NCT00246519, NCT00005520.
Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity
Marini, Sandro, Crawford, Katherine, Morotti, Andrea, Lee, Myung J., Pezzini, Alessandro, Moomaw, Charles J., Flaherty, Matthew L., Montaner, Joan, Roquer, Jaume, Jimenez-Conde, Jordi, Giralt-Steinhauer, Eva, Elosua, Roberto, Cuadrado-Godia, Elisa, Soriano-Tarraga, Carolina, Slowik, Agnieszka, Jagiella, Jeremiasz M., Pera, Joanna, Urbanik, Andrzej, Pichler, Alexander, Hansen, Björn M., McCauley, Jacob L., Tirschwell, David L., Selim, Magdy, Brown, Devin L., Silliman, Scott L., Worrall, Bradford B., Meschia, James F., Kidwell, Chelsea S., Testai, Fernando D., Kittner, Steven J., Schmidt, Helena, Enzinger, Christian, Deary, Ian J., Rannikmae, Kristiina, Samarasekera, Neshika, Salman, Rustam Al-Shahi, Sudlow, Catherine L., Klijn, Catharina J. M., Nieuwenhuizen, Koen M. van, Fernandez-Cadenas, Israel, Delgado, Pilar, Norrving, Bo, Lindgren, Arne, Goldstein, Joshua N., Viswanathan, Anand, Greenberg, Steven M., Falcone, Guido J., Biffi, Alessandro, Langefeld, Carl D., Woo, Daniel, Rosand, Jonathan, Anderson, Christopher D., Hardy, John , Benjamin, Emelia J. , Montaner, Joan , Rotter, Jerome I. , Seshadri, Sudha , Anderson, Christopher D. , Lubitz, Steven A. , Sudlow, Cathie , Rannikmäe, Kristiina , James, Michael L. , Testai, Fernando D. , Maguire, Jane , Brown, Devin L. , Tirschwell, David , Hansen, Björn M. , Elosúa, Roberto , Cuadrado‐Godia, Elisa , Soriano‐Tárraga, Carolina , Nieuwenhuizen, Koen M. van , Klijn, Catharina J.M. , Samarasekera, Neshika , Salman, Rustam Al‐Shahi , Pezzini, Alessandro , Delgado, Pilar , Lee, Chaeyoung , McCauley, Jacob L. , Marini, Sandro , Chen, Christopher , Bersano, Anna , van Nieuwenhuizen, Koen M , Seshadri, Sudha , Hardy, John , Montaner, Joan , Benjamin, Emelia J , Lubitz, Steven A , Rotter, Jerome I , Pezzini, Alessandro , Crawford, Katherine, Morotti, Andrea, Lee, Myung J., Moomaw, Charles J., Flaherty, Matthew L., Roquer, Jaume, Jimenez-Conde, Jordi, Giralt-Steinhauer, Eva, Slowik, Agnieszka, Jagiella, Jeremiasz M., Pera, Joanna, Urbanik, Andrzej, Pichler, Alexander, Hansen, Björn M., Selim, Magdy, Brown, Devin L., Silliman, Scott L., Worrall, Bradford B., Meschia, James F., Kidwell, Chelsea S., Kittner, Steven J., Schmidt, Helena, Enzinger, Christian, Deary, Ian J., Salman, Rustam Al-Shahi, Fernandez-Cadenas, Israel, Delgado, Pilar, Norrving, Bo, Lindgren, Arne, Goldstein, Joshua N., Viswanathan, Anand, Greenberg, Steven M., Falcone, Guido J., Biffi, Alessandro, Langefeld, Carl D., Woo, Daniel, Rosand, Jonathan, Anderson, Christopher D., Al-Shahi Salman, Rustam , Bersano, Anna , Testai, Fernando D , McCauley, Jacob L

Mayo Clinic

JAMA Neurology | February 6, 2019 | Volume: 76 | Issue: 4 | Pages: 480

10.1001/jamaneurol.2018.4519 | PMID 30726504 Get It

Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy
Ludmir, Ethan B. , Mahajan, Anita , Jones, Jeremy , Ketonen, Leena , Su, Jack , Grosshans, David R. , McAleer, Mary Frances, McGovern, Susan L. , Lassen–Ramshad, Yasmin , Adesina, Adekunle M. , Dauser, Robert C., Weinberg, Jeffrey S. , Chintagumpala, Murali , Ludmir, Ethan B , Paulino, Arnold C. , McAleer, Mary Frances

Mayo Clinic

Neuro-Oncology | February 6, 2019 | Volume: 21 | Issue: 5 | Pages: 686-695

10.1093/neuonc/noz042 | PMID 30753704 Get It

Effects of aspirin and non-steroidal anti-inflammatory drugs on the risk of cholangiocarcinoma: a meta-analysis
Lapumnuaypol, Kamolyut , Tiu, Andrew , Thongprayoon, Charat , Wijarnpreecha, Karn , Ungprasert, Patompong , Cheungpasitporn, Wisit , Cheungpasitporn, Wisit , Thongprayoon, Charat , Wijarnpreecha, Karn , Mao, Michael A.

Mayo Clinic

QJM: An International Journal of Medicine | February 6, 2019 | Volume: 112 | Issue: 6 | Pages: 421-427

10.1093/qjmed/hcz039 | PMID 30753687 Get It

Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy
Ali, Farwa , Martin, Peter R. , Botha, Hugo , Ahlskog, J. Eric , Bower, James H., Masumoto, Joseph Y., Maraganore, Demetrius M. , Hassan, Anhar , Eggers, Scott D.Z. , Drubach, Daniel A., Petersen, Ronald C. , Dunkley, Erika Driver, Gerpen, Jay Van, Uitti, Ryan J. , Whitwell, Jennifer L., Josephs, Keith A. , Eggers, Scott, Drubach, Daniel, Van Gerpen, Jay, Uitti, Ryan, Botha, Hugo , Boeve, Bradley F. , Knopman, David S. , Gerpen, Jay A. van, Whitwell, Jennifer , Dickson, Dennis W.

Mayo Clinic

Movement Disorders | February 6, 2019 | Volume: 34 | Issue: 8 | Pages: 1144-1153

10.1002/mds.27619 | PMID 30726566 Get It

Abstract Background In 2017, the International Parkinson and Movement Disorder Society put forward new clinical criteria for the diagnosis of PSP, recognizing diverse PSP phenotypes. In this study, we compared the sensitivity and specificity of the new criteria with the National Institutes of Neurological Disease and Society for Progressive Supranuclear Palsy criteria at different times. Methods Patients with clinical parkinsonism, clinical and/or neuropathological diagnosis of PSP, were identified from the Society for Progressive Supranuclear Palsy brain bank. All patients had neuropathologic diagnoses and detailed clinical examination performed by a neurologist at 1 of the 3 Mayo Clinic sites, in Florida, Arizona, and Minnesota. Clinical symptoms and signs were abstracted retrospectively in a blinded fashion and used to determine whether patients met either diagnostic criterion. Patients were divided into early and late disease stage groups using a 3‐year cutoff. Results A total of 129 patients were included, of whom 66 had PSP pathology (51%). The remainder had other neurodegenerative diseases. The overall sensitivity of the International Parkinson and Movement Disorder Society criteria was 87.9%, compared with 45.5% for the National Institutes of Neurological Disease and Society for Progressive Supranuclear Palsy criteria, whereas the specificity of the International Parkinson and Movement Disorder Society probable PSP criteria was 85.7%, compared with 90.5% for the National Institutes of Neurological Disease and Society for Progressive Supranuclear Palsy. Individual patients were noted to have features of multiple PSP phenotypes. Conclusion The International Parkinson and Movement Disorder Society criteria recognize several phenotypes of progressive supranuclear palsy and hence have higher sensitivity than the previous criteria. © 2019 International Parkinson and Movement Disorder Society
Physiology in Perspective: Responding to a Changing Environment
Sieck, Gary C.

Mayo Clinic

Physiology | February 6, 2019 | Volume: 34 | Issue: 2 | Pages: 84-85

10.1152/physiol.00001.2019 | PMID 30724131 Get It